US Medical Innovations, LLC, announced that Jerome Canady MD, Chief Executive Officer, USMI, will be presenting “Cold Plasma Oncotherapeutics™ and Robotic Voice-Operated Delivery System.
TAKOMA PARK, Md.--(BUSINESS WIRE)-- US Medical Innovations, LLC (USMI), a U.S. FDA-registered life science, biomedical and robotic-device company (a subsidiary of US Patent Innovations, LLC), announced today that Jerome Canady MD, Chief Executive Officer, USMI, will be presenting “Cold Plasma Oncotherapeutics™ and Robotic Voice-Operated Delivery System. The Future of Cancer Treatment” at the JMP Securities Life Sciences Conference Wednesday, June 19, 2019, 1:00 PM at the St. Regis Hotel New York, NY.
A live audio webcast of the conference presentation will be available online at http://wsw.com/webcast/jmp39/umi/ or through the company’s website at www.usmedinnovations.com/media-center/upcoming-events/. A replay of the webcast will be archived on the website for approximately 90 days.
About US Medical Innovations
US Medical Innovations, LLC (USMI), based out of Takoma Park, MD, is a privately-held FDA-registered life science, biomedical and robotic-device company. USMI is dedicated to expanding the boundaries of plasma medicine for the treatment of cancer and pioneering new surgical and robotic technologies that advance patient outcomes and improve human lives.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190606005650/en/
Contacts
Kenniah Chestnut, Esq
6930 Carroll Ave.
Takoma Park, MD 2091
301-270-0147 / KChestnut@usmedinnov.com
www.usmedinnovations.com
Source: US Medical Innovations, LLC
View this news release online at:
http://www.businesswire.com/news/home/20190606005650/en
